Health Unions Call For RSV Vaccine Fast Track Approval And Funding
Two New Zealand health unions, NZRDA and APEX, are urging the Ministry of Health and Pharmac to expedite the approval, funding, and distribution of RSV vaccines. They emphasize the strain on public hospitals and the 2,000 annual child hospitalizations due to RSV, noting that similar vaccines are already funded in Australia. The unions advocate for proactive measures to reduce the burden of disease on the healthcare system.
Why it matters
This call highlights a critical public health issue in New Zealand, aiming to reduce hospitalizations and healthcare strain by making effective RSV vaccines accessible. It underscores disparities in vaccine availability compared to neighboring countries and the proactive role of unions in public health policy.
News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | /" style="white-space: nowrap">Search
Two health unions are calling for the Ministry of Health and Pharmac to step up and organise fast-track approval, funding, purchase and distribution of vaccines which protect against respiratory syncytial virus (RSV).
The New Zealand Resident Doctors’ Association (NZRDA), representing 3000 resident doctors and the APEX Union, representing 6000 allied, scientific and technical health professionals are asking for expedited processes to get RSV vaccines into the arms of at risk New Zealanders to keep more New Zealanders healthy over winter and out of hospital.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in